Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Osteoarthritis
Interventions: Dextrose Prolotherapy, Saline Prolotherapy, At-home physical therapy exercise group; Procedure · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 40 Years to 70 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2016
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Spinal Cord Injury
Interventions: ReWalk Rehabilitation 2.0; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 12 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cerebral Palsy
Interventions: Targeted Training for trunk control; Device
Lead sponsor: University of Hartford; Other
Eligibility: 2 Years to 12 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: West Hartford, Connecticut

Conditions: Friedreich Ataxia
Interventions: Spinal tap for CSF collection, Venipuncture for blood sample; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pre-Eclampsia
Interventions: Echocardiogrpahy and non-invasive monitoring; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obesity
Interventions: Roflumilast; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 30 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hand Rejuvination
Interventions: Restylane® Lyft; Drug
Lead sponsor: DeNova Research; Other
Eligibility: 28 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Progressive Aphasia
Interventions: Transcranial Direct Current Stimulation (tDCS), Sham tDCS, Modified Contraint-Induced Language Therapy (mCILT); Device · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 45 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hearing Loss, Ear Diseases, Hearing Disorders, Otolaryngological Disease
Interventions: Remote Fitting, In-Office Fitting; Device
Lead sponsor: Advanced Bionics; Industry
Eligibility: 13 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Plasma Cell Myeloma
Interventions: isatuximab SAR650984, Pomalidomide, Dexamethasone, Carfilzomib; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 583 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 24
States / cities: Little Rock, Arkansas • Fullerton, California • San Francisco, California + 21 more

Conditions: Intervertebral Disc Degeneration
Interventions: C5-C6 arthrodesis; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 60 Years
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy Volunteers
Interventions: TAK-788, Placebo; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Stress, Anxiety, Depression
Interventions: Exposure to relaxant and stimulant odors; Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 44 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Dysphagia
Interventions: Pharyngocise; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 90 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Obesity
Interventions: Intralipid, 20% Intravenous Emulsion, Placebos; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Chapel Hill, North Carolina

Conditions: Sessile Serrated Adenoma
Interventions: Endocuff Vision Assisted Colonoscopy; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 45 Years to 85 Years
Enrollment: 427 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Lymphoma, Leukemia
Interventions: Zevalin Radioimmunotherapy, Rituximab, Fludarabine, Cyclophosphamide, Allogeneic Stem Cell Transplantation; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Melanoma (Skin)
Interventions: ADI-PEG-20, Pharmacology Studies; Biological · Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 120 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Healthy
Interventions: Prochlorperazine suppositories, 25mg, Compazine® suppositories, 25mg; Drug
Lead sponsor: Padagis LLC; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Irritable Bowel Syndrome
Interventions: DS-01; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation
Interventions: Internal Cardioversion, External Cardioversion; Procedure
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years to 99 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Smoker
Interventions: Survey Administration; Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Acellular Pertussis, Tetanus, Diphtheria
Interventions: Boostrix®, Menactra™; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 11 Years to 18 Years
Enrollment: 1,344 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 24
States / cities: Chandler, Arizona • Little Rock, Arkansas • Fountain Valley, California + 18 more

Conditions: Tonsillectomy
Interventions: Honey, Standard of Care; Dietary Supplement · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 2 Years to 17 Years
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Joint Injections for Osteoarthritic Knee Pain

Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

Case Series_Targeted Training for Trunk Control Cerebral Palsy

Measurement of Frataxin mRNA in Biofluids

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions

Treating Primary Progressive Aphasia (PPA) Using tDCS

Evaluation of Remote Fitting in Adult and Pediatric Users of the HiResolution Bionic Ear System

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Adjacent Segment Mechanics in Cervical Arthrodesis Patients

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants

The Effects of Smell on Mood and Physical Responses

Pharyngocise Dose Response Study

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

Use of a Distal Colonoscope Attachment to Increase Detection of Sessile Serrated Adenomas

Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery

Bioavailability of Prochlorperazine Suppositories, 25 mg

SH-DS01 on Fecal Metagenomic Stability

The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation

Online Survey in Studying Smoking Attitudes and Behaviors Among Current Smokers

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Honey Used as Adjunct Therapy to Tylenol for Post-Op Tonsillectomy Patients